Roche enters into a definitive agreement to acquire LumiraDx

Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform

Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , United Kingdom , Japan , Switzerland , Matt Sause , Veronique Ameye , Roche Group , Genentech , Clinical Chemistry , Chief Executive Officer , Dow Jones Sustainability Indices , Chugai Pharmaceutical , Press Release Image , Transformative , Joint , Mare , Solution , Complement , Coches , Decentralised , Iagnostics , Portfolio , Linical , Chemistry , Immunochemistry , Coagulation , Olecular , Multiple , Disease , Areas , Umiradxs , Technology , Ntegrates , Tests , Simple , Tse , Single , Instrument , Rings , Affordable , Ccessible , Testing , Patients , Orldwide , Terms , Agreement , , Oche , Bay , Purchase , Price , Sd , 95 , Billion , Reddit , Ebwire , Press Release , Ews Release ,